Sidney Kimmel Cancer Center – Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

Sidney Kimmel Cancer Center – Jefferson Health (SKCC) and Sarah Cannon Research Institute (Sarah Cannon) recently announced a unique collaboration to advance clinical research through an expanded early phase drug development program and investigator initiated trials, leveraging the strengths of each. The organizations will combine expertise in drug development and research support services, which will …


Kevin Kelly, DO, Receives “Director’s Award for Impact” at Member Retreat

Congratulations to Wm. Kevin Kelly, DO, Professor of Medical Oncology and Director of the Division of Solid Tumor Oncology, for receiving the “Director’s Award for Impact” at the recent Sidney Kimmel Cancer Center at Jefferson Health (SKCC) Member Retreat, held at Citizens Bank Park in Philadelphia. Kelly, who is also the leader of the Prostate Cancer …


Bench to Bedside: How to Fast Track Targeted Cancer Drugs with Radiation into the Clinic

Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical development of targeted cancer drugs in combination with radiation therapy. The suggested strategic guidelines, published in the Journal of the National Cancer Institute in a recent commentary …